Synonyms
Status
Molecule Category UNKNOWN
UNII 2ZL2BA06FU
EPA CompTox DTXSID70173639

Structure

InChI Key JBPUGFODGPKTDW-SFHVURJKSA-N
Smiles COc1cc(NC(=O)Nc2cccc(CNC(=O)O[C@H]3CCOC3)c2)ccc1-c1cnco1
InChI
InChI=1S/C23H24N4O6/c1-30-20-10-17(5-6-19(20)21-12-24-14-32-21)27-22(28)26-16-4-2-3-15(9-16)11-25-23(29)33-18-7-8-31-13-18/h2-6,9-10,12,14,18H,7-8,11,13H2,1H3,(H,25,29)(H2,26,27,28)/t18-/m0/s1

Physicochemical Descriptors

Property Name Value
Molecular Formula C23H24N4O6
Molecular Weight 452.47
AlogP 4.01
Hydrogen Bond Acceptor 7.0
Hydrogen Bond Donor 3.0
Number of Rotational Bond 7.0
Polar Surface Area 123.95
Molecular species NEUTRAL
Aromatic Rings 3.0
Heavy Atoms 33.0

Bioactivity

Mechanism of Action Action Reference
Inosine-5'-monophosphate dehydrogenase 1 inhibitor INHIBITOR PubMed
Protein: Inosine-5'-monophosphate dehydrogenase 1

Description: Inosine-5'-monophosphate dehydrogenase 1

Organism : Homo sapiens

P20839 ENSG00000106348
Targets EC50(nM) IC50(nM) Kd(nM) Ki(nM) Inhibition(%)
Enzyme Oxidoreductase
- 10-11 - - -
Assay Description Organism Bioactivity Reference
In vitro secondary T-cell (CEM) proliferation assay Homo sapiens 430.0 nM
Inhibition of CEM (human leukemia) cell proliferation. Homo sapiens 490.0 nM
Inhibitory activity against proliferation of CEM cell line Homo sapiens 490.0 nM
Inhibition of human inosine-5'-monophosphate dehydrogenase 2 None 10.0 nM
Inhibitory activity against inosine monophosphate dehydrogenase IMPDH II None 10.0 nM
Inhibitory activity tested against inosine-5'-monophosphate dehydrogenase 2 (IMPDH-II) enzyme None 11.0 nM
Inhibition of inositol-5-monophosphate dehydrogenase (IMPDH); range 7-8 nM None 7.0 nM
Inhibitory activity against proliferation of peripheral blood mononuclear cells Homo sapiens 170.0 nM
Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of Caco-2 cells at 10 uM after 48 hours by high content imaging Homo sapiens 22.07 %
Inhibition of IMPDH in Zika virus MR766 infected in human HuH7 cells assessed as antiviral activity by measuring reduction in viral replication preincubated for 12 hrs followed by viral infection and measured day 2 post infection by qRT-PCR method Zika virus 600.0 nM
SARS-CoV-2 3CL-Pro protease inhibition percentage at 20µM by FRET kind of response from peptide substrate Severe acute respiratory syndrome coronavirus 2 16.9 %
Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging Chlorocebus sabaeus 1.02 % Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging Chlorocebus sabaeus 1.02 %

Related Entries

Cross References

Resources Reference
ChEMBL CHEMBL304087
DrugBank DB04862
FDA SRS 2ZL2BA06FU
Guide to Pharmacology 10741
PubChem 153241
SureChEMBL SCHEMBL329922
ZINC ZINC000003975663